219 related articles for article (PubMed ID: 12643444)
1. Interphase fish analysis of cell cycle genes in asbestos-treated human mesothelial cells (HMC), SV40-transformed HMC (MeT-5A) and mesothelioma cells (COLO).
Dopp E; Poser I; Papp T
Cell Mol Biol (Noisy-le-grand); 2002; 48 Online Pub():OL271-7. PubMed ID: 12643444
[TBL] [Abstract][Full Text] [Related]
2. Effects of asbestos on initiation of DNA damage, induction of DNA-strand breaks, P53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells.
Burmeister B; Schwerdtle T; Poser I; Hoffmann E; Hartwig A; Müller WU; Rettenmeier AW; Seemayer NH; Dopp E
Mutat Res; 2004 Mar; 558(1-2):81-92. PubMed ID: 15036122
[TBL] [Abstract][Full Text] [Related]
3. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.
Murthy SS; Testa JR
J Cell Physiol; 1999 Aug; 180(2):150-7. PubMed ID: 10395284
[TBL] [Abstract][Full Text] [Related]
4. SV40 infection induces telomerase activity in human mesothelial cells.
Foddis R; De Rienzo A; Broccoli D; Bocchetta M; Stekala E; Rizzo P; Tosolini A; Grobelny JV; Jhanwar SC; Pass HI; Testa JR; Carbone M
Oncogene; 2002 Feb; 21(9):1434-42. PubMed ID: 11857086
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of malignant pleural mesothelioma.
Jaurand MC; Fleury-Feith J
Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.
Usami N; Fukui T; Kondo M; Taniguchi T; Yokoyama T; Mori S; Yokoi K; Horio Y; Shimokata K; Sekido Y; Hida T
Cancer Sci; 2006 May; 97(5):387-94. PubMed ID: 16630136
[TBL] [Abstract][Full Text] [Related]
7. Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis.
Aung W; Hasegawa S; Furukawa T; Saga T
Carcinogenesis; 2007 Sep; 28(9):2047-52. PubMed ID: 17434931
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular genetic changes in malignant mesothelioma.
Musti M; Kettunen E; Dragonieri S; Lindholm P; Cavone D; Serio G; Knuutila S
Cancer Genet Cytogenet; 2006 Oct; 170(1):9-15. PubMed ID: 16965949
[TBL] [Abstract][Full Text] [Related]
9. SV40 and cell cycle perturbations in malignant mesothelioma.
Testa JR; Giordano A
Semin Cancer Biol; 2001 Feb; 11(1):31-8. PubMed ID: 11243897
[TBL] [Abstract][Full Text] [Related]
10. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma.
Cacciotti P; Libener R; Betta P; Martini F; Porta C; Procopio A; Strizzi L; Penengo L; Tognon M; Mutti L; Gaudino G
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12032-7. PubMed ID: 11572935
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the molecular analysis of human malignant mesothelioma.
De Rienzo A; Testa JR
Clin Ter; 2000; 151(6):433-8. PubMed ID: 11211478
[TBL] [Abstract][Full Text] [Related]
12. Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells.
Sekido Y
Cancer Sci; 2010 Jan; 101(1):1-6. PubMed ID: 19793348
[TBL] [Abstract][Full Text] [Related]
13. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells.
Pietruska JR; Kane AB
Cancer Res; 2007 Apr; 67(8):3637-45. PubMed ID: 17440075
[TBL] [Abstract][Full Text] [Related]
14. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.
Fleury-Feith J; Lecomte C; Renier A; Matrat M; Kheuang L; Abramowski V; Levy F; Janin A; Giovannini M; Jaurand MC
Oncogene; 2003 Jun; 22(24):3799-805. PubMed ID: 12802287
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.
Ke Y; Reddel RR; Gerwin BI; Reddel HK; Somers AN; McMenamin MG; LaVeck MA; Stahel RA; Lechner JF; Harris CC
Am J Pathol; 1989 May; 134(5):979-91. PubMed ID: 2541616
[TBL] [Abstract][Full Text] [Related]
16. LATS2 is a tumor suppressor gene of malignant mesothelioma.
Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
[TBL] [Abstract][Full Text] [Related]
17. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma.
Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC
Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L
Clin Cancer Res; 2007 Oct; 13(19):5942-51. PubMed ID: 17908991
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma.
Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL
Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813
[TBL] [Abstract][Full Text] [Related]
20. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure.
Cacciotti P; Barbone D; Porta C; Altomare DA; Testa JR; Mutti L; Gaudino G
Cancer Res; 2005 Jun; 65(12):5256-62. PubMed ID: 15958571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
